Shreya Group

Shreya Group is a prominent Indian pharmaceutical and biotechnology organization with a significant international footprint, particularly in Russia, the CIS region, and Africa. Headquartered in Mumbai, the group's flagship entity, Shreya Life Sciences, operates across diverse therapeutic segments including cardiology, diabetology, gastrointestinal, and anti-infectives. The company is notably recognized for its production of recombinant human insulin under the brand name Recosulin, marking its successful expansion into the biopharmaceutical space. Shreya Group maintains state-of-the-art manufacturing facilities in India that comply with international GMP standards, supporting a robust export business of branded generics. Their integrated business model encompasses research, manufacturing, and an extensive global distribution network tailored for emerging markets.